Takung Art Co., Ltd. TKAT Income Statement

Takung art co., ltd. (TKAT)

Income statement / Quarterly

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Jun'12	Mar'12
Revenue
Listing fee
-4	0	0	289	-71	0	2,000	1,978	966	1,455	843	2,307	2,748	2,968	3,002	2,195	-	439	606	-	-	-	-	-	-	-	-	-	-	-	-
Commission
-	939	532	-	-	253	1,668	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Commission
-	-	-	178	-	-	-	1,635	1,142	1,496	1,803	1,670	1,676	1,669	926	1,143	-	2,239	301	-	-	-	-	-	-	-	-	-	-	-	-
Authorized agent subscription revenue
-	-	-	0	-	-	-	191	0	0	0	0	83	322	322	321	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Management fee
104	184	93	68	113	107	178	168	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Online art sales
-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Management fee
-	-	-	-	-	-	-	-	-	402	272	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Management fee
-	-	-	-	-	-	-	-	-	-	-	292	420	781	431	128	-	26	28	-	-	-	-	-	-	-	-	-	-	-	-
Authorized agent subscription revenue
-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Online artwork sales
-	0	0	-	-	2	6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Annual fee
-	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Total revenue
887	1,123	626	535	303	363	3,854	3,974	2,376	3,355	2,919	4,271	4,929	5,742	4,683	3,788	6,418	2,706	936	1,274	2,284	921	468	1,045	-	0	0	-	0	-	-
Cost of revenue
572	580	441	267	405	299	940	933	424	292	267	262	306	285	275	262	213	214	200	177	138	119	99	77	-	-	0	-	0	-	-
Net Sales
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0
Cost of Goods Sold
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0
Gross profit
314	543	185	268	-101	64	2,913	3,040	1,951	3,062	2,651	4,008	4,622	5,456	4,407	3,526	6,205	2,491	735	1,097	2,146	802	368	968	-	-	0	0	0	0	0
Operating expenses
General and administrative expenses
1,339	1,159	888	1,274	3,532	2,208	2,574	3,008	4,799	2,498	2,238	2,573	2,222	1,744	1,770	1,561	1,127	882	601	466	739	415	313	233	-	-	24	-	0	-	-
Selling expenses
158	108	3	30	46	149	458	243	123	624	310	337	278	652	703	638	410	116	48	9	-	-	-	-	-	-	-	-	-	-	-
Impairment loss
-	0	-	-	-	326	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment loss construction-in-progress
-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	41	-	51	-	34	30
Selling, general, and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	25	-	41	-	28	29
Total operating expenses
1,498	1,267	892	1,305	3,605	2,683	3,033	3,252	4,923	3,122	2,549	2,910	-	-	-	2,199	-	-	-	-	-	-	-	-	-	67	-	92	-	62	60
Loss from operations
-1,183	-724	-707	-1,036	-3,707	-2,619	-119	-211	-2,971	-60	102	1,098	2,121	3,059	1,934	1,327	4,667	1,492	86	621	502	387	54	734	183	-67	-24	-92	0	-62	-60
Other income and expenses:
Interest Income (Expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0	-	-0	-0
Other (expenses) income
25	13	-79	-21	-13	65	165	239	136	186	141	112	102	163	99	50	14	-0	0	0	-	0	-	-	-	-	-	0	-	0	0
Loan interest expense
-	18	0	-	69	199	149	154	145	152	153	149	139	62	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Exchange loss
317	-515	-407	358	-204	-870	-1,255	992	610	177	228	120	14	-112	-538	119	-158	-4	0	0	-	-	-	-	-	-	-	-	-	-	-
Grant from National Institute of Health
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-
Interest (expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-
Total other loss
303	-520	-486	336	-287	-1,004	-1,239	1,077	601	211	216	83	-23	-11	-438	170	-144	-5	0	0	-	-	-	-	-	-0	-	-0	-	-0	-0
Other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-
Other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	-
Loss before income tax expense
-879	-1,245	-1,194	-700	-3,995	-3,624	-1,358	865	-2,370	151	318	1,181	2,098	3,048	1,496	1,497	4,522	1,487	86	621	504	387	54	734	-	-67	-24	-	0	-	-
Income taxes (expense) benefit
248	-117	-66	8	94	-742	-273	442	-161	124	72	307	392	596	379	401	801	343	9	127	105	68	13	125	4	0	-0	-0	0	0	-0
Net loss
-1,128	-1,127	-1,127	-708	-4,089	-2,881	-1,084	423	-2,208	27	246	873	1,706	2,451	1,116	1,096	3,720	1,144	77	494	398	319	41	609	181	-67	-23	-93	0	-63	-62
Foreign currency translation adjustment
-16	-12	64	-5	149	-3	-111	-17	65	311	252	134	-1,100	10	-3	12	20	-22	0	-0	2	-4	-0	2	-	-	-0	-	0	-	-
Comprehensive loss
-1,145	-1,140	-1,062	-714	-3,939	-2,885	-1,195	406	-2,143	338	498	1,008	605	2,461	1,112	1,108	3,741	1,121	78	493	401	315	40	612	-	-	-23	-	0	-	-
Loss per common stock - basic
-0.10	-0.10	-0.10	-0.06	-0.36	-0.26	-0.10	0.04	-0.20	0.00	0.02	0.08	0.16	0.23	0.11	0.10	0.39	0.12	0.01	0.05	-	-	-	-	-	-	-	0.00	-	0.00	0.00
Loss per common stock - diluted
-0.10	-0.10	-0.10	-0.06	-0.36	-0.26	-0.10	0.04	-0.20	0.00	0.02	0.08	0.14	0.22	0.10	0.10	0.38	0.12	0.01	0.05	-	-	-	-	-	-	-	-	-	-	-
Weighted average number of common shares outstanding -basic
11,255	11,255	11,247	11,226	11,226	11,226	11,217	11,204	11,200	11,188	11,188	10,733	10,667	10,632	10,632	10,632	10,127	9,612	9,332	9,332	-	-	-	-	-	-	-	23,040	-	22,744	22,478
Weighted average number of common shares outstanding -diluted
11,255	11,255	11,247	11,226	11,207	11,226	11,217	11,223	10,135	11,248	11,416	11,509	11,412	11,365	11,311	11,147	10,349	9,612	9,332	9,332	-	-	-	-	-	23,079	-	-	-	-	-
Earnings per common share - basic and diluted (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.04	0.00	0.00	-	0.00	-	-	-	-	-
Weighted average number of common shares outstanding - basic and diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8,339	8,339	209,976	-	-	-	-	-	-	-